Your browser doesn't support javascript.
loading
Enhancement of intestinal absorption of 2-methyl cytidine prodrugs.
Cianetti, Simona; Cooper, Vincent Brett; Attenni, Barbara; Pucci, Vincenzo; Fiore, Fabrizio; Giuliano, Claudio; Laufer, Ralph; Gardelli, Cristina; Monteagudo, Edith; Narjes, Frank; Pearce, Gareth Edward; Rowley, Michael.
Afiliación
  • Cianetti S; IRBM, Merck Research Laboratories, Via Pontina Km 30600, 00040, Pomezia (RM), Italy. simona.cianetti@novartis.com
Drug Deliv ; 17(4): 214-22, 2010 May.
Article en En | MEDLINE | ID: mdl-20233089
The purpose of this study was to investigate the in vivo absorption enhancement of a nucleoside (phosphoramidate prodrug of 2'-methyl-cytidine) anti-viral agent of proven efficacy by means of intestinal permeation enhancers. Natural nucleosides are hydrophilic molecules that do not rapidly penetrate cell membranes by diffusion and their absorption relies on specialized transporters. Therefore, the oral absorption of nucleoside prodrugs and the target organ concentration of the biologically active nucleotide can be limited due to poor permeation across the intestinal epithelium. In the present study, the specificity, concentration dependence, and effect of four classes of absorption promoters, i.e. fatty acids, steroidal detergents, mucoadhesive polymers, and secretory transport inhibitors, were evaluated in a rat in vivo model. Sodium caprate and alpha-tocopheryl-polyethyleneglycol-1000-succinate (TPGS) showed a significant effect in increasing liver concentration of nucleotide (5-fold). These results suggested that both excipients might be suited in a controlled release matrix for the synchronous release of the drug and absorption promoter directly to the site of absorption and highlights that the effect is strictly dependent on the absorption promoter dose. The feasibility of such a formulation approach in humans was evaluated with the aim of developing a solid dosage form for the peroral delivery of nucleosides and showed that these excipients do provide a potential valuable tool in pre-clinical efficacy studies to drive discovery programs forward.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Profármacos / Citidina / Absorción Intestinal Límite: Animals / Humans / Male Idioma: En Revista: Drug Deliv Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2010 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Profármacos / Citidina / Absorción Intestinal Límite: Animals / Humans / Male Idioma: En Revista: Drug Deliv Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2010 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido